Answers are grounded in this paper and cite their sources.
RATIONALE: Guidelines have provided positive recommendations for pulmonary rehabilitation after severe exacerbations of chronic obstructive pulmonary disease (COPD), but results are heterogeneous and new randomised controlled trials (RCTs) continue to be published. OBJECTIVES: To assess the effects of pulmonary rehabilitation after COPD exacerbations on hospital admissions (critical outcome) and other important and patient-centred outcomes (mortality, health-related quality of life (HRQL) and exercise capacity). SEARCH METHODS: We identified studies through searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE ALL, Embase, ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP). Searches were current to 2 June 2026. ELIGIBILITY CRITERIA: RCTs comparing pulmonary rehabilitation of any duration (at least exercise training but no minimum number of exercise sessions) after exacerbation of COPD versus usual care were eligible. Usual care groups received conventional community care without rehabilitation. OUTCOMES: The four main outcomes were hospital readmissions, mortality, HRQL and exercise capacity. RISK OF BIAS: We assessed the risk of bias in the included RCTs as high, low or unclear, using the Cochrane RoB 1 tool. SYNTHESIS METHODS: We expected substantial heterogeneity across trials due to the diversity of rehabilitation programmes (i.e. number of completed exercise sessions; type, intensity and supervision of exercise training; and patient education), duration of follow-up (under three months versus three months or longer) and risk of bias (random sequence generation, allocation concealment and blinding). Therefore, we conducted prespecified subgroup analyses. We used random-effects models and standard Cochrane methods for this update, and assessed the certainty of evidence using GRADE. INCLUDED STUDIES: For this update, we added 20 studies and included a total of 40 studies (2825 participants). SYNTHESIS OF Heterogeneity appeared to be driven mainly by differences between studies showing very large effects and those showing smaller effects but still evidence of between-group differences. The overall results of this review have not changed to an important extent compared with results reported in the previous version of this review. Overall, the risk of bias was judged to be low or unclear across most domains. However, the lack of participant blinding raised concerns for subjectively reported outcomes (HRQL). High risks of selection bias and attrition bias were identified in a small number of studies, while a larger proportion of studies were at high risk for reporting bias. Egger's test indicated evidence of funnel plot asymmetry for hospital readmission (P = 0.02) and mortality (P = 0.02), but not for SGRQ (P = 0.45) or the six-minute walk test (P = 0.12). Visual inspection suggested that the asymmetry was more consistent with small-study effects than with clear evidence of missing negative studies. AUTHORS' CONCLUSIONS: Moderate-certainty evidence indicates that pulmonary rehabilitation likely reduces hospital readmissions, while evidence for mortality is of low certainty. However, some recent studies showed no benefit of rehabilitation on hospital readmissions and mortality. Such heterogeneity of effects on hospital readmissions and mortality may be explained to some extent by the extensiveness of rehabilitation programmes and by the methodological quality of the included studies. High-certainty evidence shows moderate to large effects of pulmonary rehabilitation on HRQL and exercise capacity in people with COPD after an exacerbation. While additional RCTs comparing rehabilitation to no rehabilitation seem questionable scientifically and ethically, future research must investigate how rehabilitation programmes can be designed and implemented to be feasible, cost-effective and attractive and accessible for patients and healthcare providers in the long term. Research must also investigate how the organisation of such programmes within specific healthcare systems determines their effects after COPD exacerbations on hospital readmissions and mortality. FUNDING: This Cochrane review had no dedicated funding. REGISTRATION: Protocol (2005) DOI: 10.1002/14651858.CD005305 Original review (2009) DOI: 10.1002/14651858.CD005305.pub2 Review update (2011) DOI: 10.1002/14651858.CD005305.pub3 Review update (2016) DOI: 10.1002/14651858.CD005305.pub4.
No takes yet. Share an insight, caveat, or question.
Weber et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: